Global Myasthenia Gravis Market Outlook to 2026 - A $3.65 Billion Opportunity, Hindered by Limited Availability of FDA Approved Drugs & Costly Treatment Options - ResearchAndMarkets.com
The "Myasthenia Gravis - Global Market Outlook (2017-2026)" report has been added to ResearchAndMarkets.com's offering.
- The "Myasthenia Gravis - Global Market Outlook (2017-2026)" report has been added to ResearchAndMarkets.com's offering.
- According to this report, the Global Myasthenia Gravis market accounted for $1,215 million in 2017 and is expected to reach $3,651.25 million by 2026 growing at a CAGR of 13% during the forecast period.
- However, limited availability of FDA approved drugs and costly treatment options are some issues restricting the market growth.
- Based on geography, Asia Pacific region is expected to register highest market growth rate during the forecast period.